Macleods Pharma USA Inc. is recalling 4,694 bottles of Pioglitazone and Metformin Hydrochloride Tablets (15 mg/500 mg), a prescription medication used to manage blood sugar in adults with type 2 diabetes. The recall was initiated because testing found the tablets were subpotent, meaning they contain less of the active medication than required by safety specifications. Using subpotent medication may result in higher blood sugar levels than intended, which can affect the management of diabetes. Consumers should contact their doctor or pharmacist immediately to discuss treatment alternatives.
The affected medication contains lower levels of active ingredients than specified, which can lead to ineffective treatment and Poor control of blood glucose levels for patients with type 2 diabetes.
Healthcare consultation and pharmacy return
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.